|
Name |
Methyl 6-oxoheptanoate
|
Molecular Formula | C8H14O3 | |
IUPAC Name* |
methyl 6-oxoheptanoate
|
|
SMILES |
CC(=O)CCCCC(=O)OC
|
|
InChI |
InChI=1S/C8H14O3/c1-7(9)5-3-4-6-8(10)11-2/h3-6H2,1-2H3
|
|
InChIKey |
BSBYQAYWPXHLPQ-UHFFFAOYSA-N
|
|
Synonyms |
Methyl 6-oxoheptanoate; 2046-21-1; Heptanoic acid, 6-oxo-, methyl ester; 6-oxo-heptanoic acid methyl ester; MFCD22376711; Methyl6-Oxoheptanoate; Methyl 6-oxo-heptanoate; Methyl 6-oxoheptanoate, 95%; SCHEMBL1706595; DTXSID40302070; 5-Acetylvaleric acid, methyl ester; CAA04621; ZINC1683083; NSC148317; AKOS016005447; CS-W022881; DS-3805; NSC 148317; NSC-148317; DA-19414; SY046102; FT-0704371; F16317; EN300-7419055
|
|
CAS | 2046-21-1 | |
PubChem CID | 288022 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 158.19 | ALogp: | 0.5 |
HBD: | 0 | HBA: | 3 |
Rotatable Bonds: | 6 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 43.4 | Aromatic Rings: | 0 |
Heavy Atoms: | 11 | QED Weighted: | 0.452 |
Caco-2 Permeability: | -4.439 | MDCK Permeability: | 0.00002870 |
Pgp-inhibitor: | 0.173 | Pgp-substrate: | 0.005 |
Human Intestinal Absorption (HIA): | 0.008 | 20% Bioavailability (F20%): | 0.02 |
30% Bioavailability (F30%): | 0.644 |
Blood-Brain-Barrier Penetration (BBB): | 0.997 | Plasma Protein Binding (PPB): | 33.34% |
Volume Distribution (VD): | 0.546 | Fu: | 76.56% |
CYP1A2-inhibitor: | 0.315 | CYP1A2-substrate: | 0.611 |
CYP2C19-inhibitor: | 0.237 | CYP2C19-substrate: | 0.833 |
CYP2C9-inhibitor: | 0.036 | CYP2C9-substrate: | 0.815 |
CYP2D6-inhibitor: | 0.012 | CYP2D6-substrate: | 0.503 |
CYP3A4-inhibitor: | 0.019 | CYP3A4-substrate: | 0.225 |
Clearance (CL): | 8.555 | Half-life (T1/2): | 0.914 |
hERG Blockers: | 0.014 | Human Hepatotoxicity (H-HT): | 0.161 |
Drug-inuced Liver Injury (DILI): | 0.131 | AMES Toxicity: | 0.01 |
Rat Oral Acute Toxicity: | 0.01 | Maximum Recommended Daily Dose: | 0.064 |
Skin Sensitization: | 0.339 | Carcinogencity: | 0.048 |
Eye Corrosion: | 0.949 | Eye Irritation: | 0.946 |
Respiratory Toxicity: | 0.025 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000516 | 0.763 | D0OL6O | 0.486 | ||||
ENC000758 | 0.611 | D0E4WR | 0.333 | ||||
ENC000235 | 0.606 | D0AY9Q | 0.315 | ||||
ENC000250 | 0.515 | D0ZI4H | 0.301 | ||||
ENC000253 | 0.513 | D09QEI | 0.277 | ||||
ENC001253 | 0.487 | D0Y7ZD | 0.268 | ||||
ENC000234 | 0.486 | D0FD0H | 0.262 | ||||
ENC000735 | 0.486 | D0O4GY | 0.262 | ||||
ENC001696 | 0.476 | D06VNK | 0.256 | ||||
ENC000254 | 0.472 | D09ANG | 0.256 |